Traduction de «démence de la maladie de huntington » (Français → Anglais) :

Dementia in Huntington's disease (G10+)

Definition: A dementia occurring as part of a widespread degeneration of the brain. The disorder is transmitted by a single autosomal dominant gene. Symptoms typically emerge in the third and fourth decade. Progression is slow, leading to death usually within 10 to 15 years. | Dementia in Huntington's chorea

chronic progressive hereditary chorea | Huntington chorea | Huntington disease | Huntington's chorea | Huntington's disease | HD [Abbr.]

Definition: Dementia in Alzheimer's disease with onset before the age of 65, with a relatively rapid deteriorating course and with marked multiple disorders of the higher cortical functions. | Alzheimer's disease, type 2 Presenile dementia, Alzheimer's type Primary degenerative dementia of the Alzheimer's type, presenile onset

Huntington's chorea [ Huntington's disease ]

Huntington's chorea | chronic progressive hereditary chorea | chronic progressive chorea | degenerative chorea | hereditary chorea | Huntington's disease | HD

Huntington Disease Awareness Month

The National Advisory Council on Aging position on Alzheimer disease and related dementias [ The NACA position on Alzheimer disease and related dementias ]

V. whereas age is a risk factor for the development of neurodegenerative diseases such as Alzheimer’s disease (the most common form of dementia); whereas neurodegenerative diseases are more frequent in the over-65s (they affect about 1 person in 20 over 65, 1 in 5 over 80 and 1 in 3 over 90); whereas over 7,3 million people in Europe suffer from dementia; whereas studies show that the Alzheimer’s disease rate among women over 90 is 81,7 % (compared with 24 % for men); whereas stigma and lack of awareness about neurodegenerative diseases such as dementia leads to delayed diagnosis and a poor treatment outcome;

Furthermore, broad epidemiological and clinical studies as well as better research into dementia and Alzheimer’s are important factors in the fight against dementias.

In this context, I think that Member States must develop long-term policies and action plans for speeding up access to research funding in the field of dementia and Alzheimer’s, including research into prevention, at a level commensurate with these illnesses’ economic impact on society.

breeding animals with genetic disorders that are expected to experience severe and persistent impairment of general condition, for example Huntington’s disease, Muscular dystrophy, chronic relapsing neuritis models;